No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ATYR aTyr Pharma
- 3.420
- +0.040+1.18%
Close Dec 24 13:00 ET
- 3.480
- +0.060+1.75%
Post 17:01 ET
287.08MMarket Cap-3.64P/E (TTM)
3.445High3.280Low371.68KVolume3.420Open3.380Pre Close1.25MTurnover0.48%Turnover RatioLossP/E (Static)83.94MShares3.80052wk High4.40P/B263.05MFloat Cap1.39052wk Low--Dividend TTM76.92MShs Float396.060Historical High--Div YieldTTM4.88%Amplitude1.080Historical Low3.370Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
ATyr Pharma, Inc. (NASDAQ:ATYR) Is a Favorite Amongst Institutional Investors Who Own 57%
ATyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Express News | ATyr Pharma Announces the Appointment of Eric Benevich to Its Board of Directors
JonesTrading Maintains ATyr Pharma(ATYR.US) With Buy Rating, Maintains Target Price $22
H.C. Wainwright Maintains ATyr Pharma(ATYR.US) With Buy Rating, Maintains Target Price $35
Positive Outlook for ATyr Pharma: Favorable Phase 3 Progress and Competitive Advantage Highlight Buy Rating
Heat List
US
Overall
Symbol
Price
% Chg
No Data